Shopping Cart 0
Cart Subtotal
USD 0

Cellmid Ltd (CDY) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair loss products and evolis products. Cellmid develops CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. The company markets its products in Australia and Japan. Cellmid is headquartered in Sydney, New South Wales, Australia.

Cellmid Ltd (CDY)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cellmid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cellmid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cellmid Ltd, Medical Equipment, Deal Details 10

Partnerships 10

Fujikura Kasei Exercises Option For Licensing Agreement With Cellmid For Anti-Midkine Diagnostic Antibodies 10

Equity Offering 11

Cellmid Raises USD0.7 Million in Share Purchase Plan of Shares 11

Cellmid Raises USD1.3 Million in First Tranche of Private Placement of Shares 12

Cellmid to Raise USD5.4 Million in Second Tranche of Private Placement of Shares 13

Cellmid to Raise USD0.8 Million in Private Placement of Shares 14

Cellmid Raises USD3.19 Million in Private Placement of Shares 15

Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 16

Cellmid Completes Private Placement Of Shares For USD 1.8 Million 17

Cellmid Completes Private Placement Of Shares For USD 2 Million 18

Cellmid Completes Private Placement Of Shares For USD 0.3 Million 19

Cellmid Ltd-Key Competitors 20

Cellmid Ltd-Key Employees 21

Cellmid Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Jul 31, 2018: Cellmid notes to the appendix 4c-growing consumer health sales drive revenue uplift 23

Sep 27, 2017: Cellmid's FY2017 Results Presentation 25

Corporate Communications 26

Oct 16, 2017: Cellmid Appoints Dr Martin Cross as Non-executive Director 26

Legal and Regulatory 27

Nov 02, 2018: Ikon legal action-decision handed down 27

May 29, 2018: Cellmid announces Change of Address 28

Product News 29

May 30, 2018: 5th Midkine Symposium Reinforces Clinical Potential For Cellmid'S Biotechnology Assets 29

Other Significant Developments 31

Jan 09, 2018: Cellmid Quarterly Operational Update 31

Oct 25, 2017: Cellmid: Notes to the Appendix 4C 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Cellmid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Cellmid Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cellmid Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cellmid Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Cellmid Ltd, Medical Equipment, Key Facts, 2018 2

Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Cellmid Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cellmid Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cellmid Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cellmid Ltd, Deals By Market, 2012 to YTD 2018 8

Cellmid Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Fujikura Kasei Exercises Option For Licensing Agreement With Cellmid For Anti-Midkine Diagnostic Antibodies 10

Cellmid Raises USD0.7 Million in Share Purchase Plan of Shares 11

Cellmid Raises USD1.3 Million in First Tranche of Private Placement of Shares 12

Cellmid to Raise USD5.4 Million in Second Tranche of Private Placement of Shares 13

Cellmid to Raise USD0.8 Million in Private Placement of Shares 14

Cellmid Raises USD3.19 Million in Private Placement of Shares 15

Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 16

Cellmid Completes Private Placement Of Shares For USD 1.8 Million 17

Cellmid Completes Private Placement Of Shares For USD 2 Million 18

Cellmid Completes Private Placement Of Shares For USD 0.3 Million 19

Cellmid Ltd, Key Competitors 20

Cellmid Ltd, Key Employees 21

Cellmid Ltd, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cellmid Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.